Open AccessRacial disparity in breast cancer: can it be mattered for prognosis and therapy
Author(s) -
Gupta Vijayalaxmi,
Haque Inamul,
Chakraborty Jinia,
Graff Stephanie,
Banerjee Snigdha,
Banerjee Sushanta K.
Publication year - 2018
Publication title -
journal of cell communication and signaling
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 44
eISSN - 1873-961X
pISSN - 1873-9601
DOI - 10.1007/s12079-017-0416-4
Subject(s) - medicine , breast cancer , race (biology) , socioeconomic status , cancer , disease , incidence (geometry) , epigenetics , health equity , health care , regimen , demography , gerontology , public health , pathology , environmental health , population , biology , sociology , biochemistry , botany , physics , gene , optics , economics , economic growth
Breast cancer (BC) has emerged as a deadly disease that affects the lives of millions of women worldwide. It is the second leading cause of cancer‐related deaths in the United States. Advancements in BC screening, preventive measures and treatment have resulted in significant decline in BC related deaths. However, unacceptable levels of racial disparity have been consistently reported, especially in African‐American (AA) women compared to European American (EA). AA women go through worse prognosis, shorter survival time and higher mortality rates, despite higher cancer incidence reported in EA. These disparities are independent of socioeconomic status, access to healthcare or age, or even the stage of BC. Recent race‐specific genetic and epigenetic studies have reported biological causes, which form the crux of this review. However, the developments are just the tip of the iceberg. Prioritizing primary research towards studying race‐specific tumor microenvironment and biological composition of the host system in delineating the cause of these disparities is utmost necessary to ameliorate the disparity and design appropriate diagnosis/treatment regimen for AA women suffering from BC. In this review article, we discuss emerging trends and exciting discoveries that reveal how genetic/epigenetic circuitry contributed to racial disparity and discussed the strategies that may help in future therapeutic development.